EUVIMEDEUVIMED entdecken
Open Access

Associations between blood-based neurodegenerative biomarkers and cognitive functioning and decline in India

Emma Nichols iD, Jinkook Lee, Alden L Gross, Masroor Anwar, Abhishek Gupta, Eileen M Crimmins, Bharat Thyagarajan, Sharmistha Dey iD

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251361934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Emma Nichols und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Cognition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mounting evidence supports the use of blood-based neurodegenerative biomarkers as a low-cost, minimally invasive tool for studying Alzheimer's disease and other dementias, but existing data largely come from clinical samples or high-income settings. Despite emphasis in the literature on the importance of understanding the utility of neurodegenerative biomarkers in diverse populations, published analyses are limited.

Objective

To assess the utility of neurodegenerative biomarkers in India by quantifying associations between biomarkers and cognitive outcomes in a nationally representative cohort study.

Methods

We quantified associations between five neurodegenerative blood biomarkers (amyloid-β 42/40 (Aβ 42/40 ), total tau, phosphorylated Tau181 (pTau-181), glial fibrillary acidic protein (GFAP), neurofilament light (NfL)) and cross-sectional and longitudinal cognitive outcomes using nationally-representative data from the Longitudinal Aging Study in India–Diagnostic Assessment of Dementia (N = 4096).

Results

We observed associations between biomarkers and cross-sectional cognitive functioning (Aβ 42/40 , GFAP, and NfL) and longitudinal cognitive change (pTau-181 and NfL). NfL had the strongest associations; each SD increase in log NfL was associated with 0.007 (95% CI 0.000 to 0.014) SD unit/year worse cognitive decline, equivalent to about 35% of the mean longitudinal decline in the sample. We saw little evidence of effect modification by demographic variables or APOE ε4 status.

Conclusions

Neurodegenerative biomarkers were associated with cross-sectional and longitudinal outcomes as well as mortality, though there was variation in outcome-specific findings across biomarkers. Findings generally support the use of neurodegenerative biomarkers in India. Future research in India should leverage these biomarkers to address a range of research topics, including heterogeneity in dementia phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionCognitionHumansIndiaBiomarkersMaleFemaleAgedCross-Sectional Studiestau ProteinsAmyloid beta-PeptidesLongitudinal StudiesMiddle AgedNeurofilament ProteinsGlial Fibrillary Acidic ProteinCohort StudiesPeptide FragmentsAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidblood-based biomarkerscognitioncognitive declinedementiaglial fibrillary acidic proteinneurodegenerationneurofilament lighttau

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament ProteinsGlial Fibrillary Acidic ProteinPeptide Fragmentsneurofilament protein L

Autor:innen und Institutionen

  • Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA.
  • Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
  • Department of Economics, University of Southern California, Los Angeles, CA, USA.
  • Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Department of Biophysics, All India Institute of Medical Sciences, New Delhi, Delhi, India.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.

ORCID-Profile: Emma Nichols, Sharmistha Dey

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Nichols, E., Lee, J., Gross, A. L., Anwar, M., Gupta, A., Crimmins, E. M., Thyagarajan, B., & Dey, S. (2025). Associations between blood-based neurodegenerative biomarkers and cognitive functioning and decline in India. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251361934

Vancouver

Nichols E, Lee J, Gross AL, Anwar M, Gupta A, Crimmins EM, et al. Associations between blood-based neurodegenerative biomarkers and cognitive functioning and decline in India. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251361934

BibTeX
@article{Nichols2025,
  author = {Nichols, Emma and Lee, Jinkook and Gross, Alden L and Anwar, Masroor and Gupta, Abhishek and Crimmins, Eileen M and Thyagarajan, Bharat and Dey, Sharmistha},
  title = {Associations between blood-based neurodegenerative biomarkers and cognitive functioning and decline in India},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251361934}
}
Kostenlos starten →